Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas-Reference-Cited by-同舟云学术

Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas

Published:2007-02-15 Issue:4 Volume:109 Page:658-667
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Wang Kim L.,Wu Tsung-Teh,Choi In Seon,Wang Huamin,Resetkova Erika,Correa Arlene M.,Hofstetter Wayne L.,Swisher Stephen G.,Ajani Jaffer A.,Rashid Asif,Albarracin Constance T.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference43 articles.

1. The epidemic of esophageal adenocarcinoma;el-Serag;Gastroenterol Clin North Am.,2002

2. Epidemiology of esophageal adenocarcinoma;Pera;J Surg Oncol.,2005

3. Skeletonizing en bloc esophagectomy for cancer;Collard;Ann Surg.,2001

4. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single center in the Western world;Siewert;Ann Surg.,2001

5. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus;Hulscher;N Engl J Med.,2002

Cited by 186 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Agents in Esophagogastric Cancer Beyond Human Epidermal Growth Factor Receptor-2;Hematology/Oncology Clinics of North America;2024-06

2. Advances in targeted therapy and immunotherapy for esophageal cancer;Chinese Medical Journal;2023-07-05

3. Immune checkpoint inhibition in advanced esophageal squamous cell carcinoma: how can we personalise management?;Journal of Thoracic Disease;2023-07

4. Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study;Cancers;2023-04-06

5. Novel Treatment Options in Metastatic Esophageal Carcinoma: Checkpoint Inhibitors in Combination Therapies;Pharmacology;2022-12-02